Indivior Pharmaceuticals, Inc. 4

Chief Accounting Officer Anderson Woodrow D bought 1,500 shares of Indivior Pharmaceuticals, Inc. common stock at about $36.28 per share.

On August 5, 2026, Anderson Woodrow D, Chief Accounting Officer of Indivior Pharmaceuticals, Inc., purchased 1,500 shares of the company’s common stock at a price of approximately $36.28 per share, for an estimated total of about $54,420. Following this open-market purchase, his direct ownership increased to 26,138 shares of Indivior common stock. No other transaction types or derivative securities were disclosed in this Form 4 filing, indicating a straightforward insider share purchase that modestly increases the officer’s equity exposure to the company.

Filing Facts

CIK

1625297

Ticker

INDV

Form

4

Source Type

fda

Accession

0002014440-26-000010

Alert Tier

6